A recent study suggests that people who discontinue new weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt conventional diet and exercise regimens.
Published data in a prominent health publication points out that while overweight people often shed about a fifth of their total mass while using the jabs, the mass is regained at an average rate of nearly a kilo each month once they quit.
"People using these drugs need to be cognizant of the risk of rapid weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery means a return to original weight within about a year and a half.
Analyzing Approaches
The research, which looked at dozens of trials involving thousands of participants, contrasted the effects of these new drugs with other pills.
Scientists note that individuals who lose weight through lifestyle changes alone generally see a slower weight regain—around 100 grams monthly—once they finish.
Understanding the Fast Rebound
Experts propose the mode of action of the jabs accounts for the amplified rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to produce less of its own natural hormone, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement means hunger is no longer kept in check, making binge eating a significant risk."
A Lifelong Condition?
Health authorities advise the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Professionals say that, due to the high risk of weight regain, the therapy might need to be long-term.
This perspective is supported by pharmaceutical companies, who note that the findings "emphasize the long-term character of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
Users who have stopped the medication explain a powerful resurgence of hunger.
"I experienced something flipping and I was suddenly ravenous," recalled an individual.
The struggle is compounded if users have not developed lasting lifestyle or habit changes during treatment.
Growing Adoption
Recent estimates show that a significant number of people in the UK have used these injections in the past year, with interest continuing to grow.
- Use is more common among women compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- Many access the medications through private healthcare rather than public health services.
In conclusion, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a magic fix and long-term success hinges on integrated behavioural changes.
